AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Lexaria Bioscience Corp. Director's Dealing 2015

Dec 17, 2015

34983_dirs_2015-12-16_797ae17b-41c4-4f78-a353-e5d483f1e050.zip

Director's Dealing

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXARIA CORP. (LXRP)
CIK: 0001348362
Period of Report: 2015-12-16

Reporting Person: Bhullar Baljinder (Director, CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-12-16	Common Shares	A	14125	—	Acquired	155375	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-07-11	Stock Options	$0.32	A	10000	Acquired	2016-07-11	Common Shares (10000)	Direct
2013-06-18	Stock Options	$0.09	A	17500	Acquired	2018-06-18	Common Shares (17500)	Direct
2014-12-23	Stock Options	$0.1	A	50000	Acquired	2019-12-23	Common Shares (50000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	141250	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$0.32	2016-07-11	Common Shares (100000)	100000	Direct
Stock Options	$0.09	2018-06-18	Common Shares (175000)	185000	Direct
Stock Options	$0.1	2019-12-23	Common Shares (500000)	802500	Direct

Footnotes

F1: Adjusted to forward 1.1 split

F2: Adjusted price to Forward 1.1 split